|
1
|
Potter JD, Slattery ML, Bostick RM and
Gapstur SM: Colon cancer: a review of the epidemiology. Epidemiol
Rev. 15:499–545. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tomlinson I, Ilyas M and Novelli M:
Molecular genetics of colon cancer. Cancer Metastasis Rev.
16:67–79. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu Y, Richardson JA, Parada LF and Graff
JM: Smad3 mutant mice develop metastatic colorectal cancer. Cell.
94:703–714. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oshima M, Oshima H and Taketo MM: TGF-beta
receptor type II deficiency results in defects of yolk sac
hematopoiesis and vasculogenesis. Dev Biol. 179:297–302. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu X, Sun Y, Constantinescu SN, Karam E,
Weinberg RA and Lodish HF: Transforming growth factor beta-induced
phosphorylation of Smad3 is required for growth inhibition and
transcriptional induction in epithelial cells. Proc Natl Acad Sci
USA. 94:10669–10674. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Graff JM, Bansal A and Melton DA: Xenopus
Mad proteins transduce distinct subsets of signals for the TGF beta
superfamily. Cell. 85:479–487. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brown JR and DuBois RN: COX-2: A molecular
target for colorectal cancer prevention. J Clin Oncol.
23:2840–2855. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Soumaoro LT, Uetake H, Higuchi T, Takagi
Y, Enomoto M and Sugihara K: Cyclooxygenase-2 expression: A
significant prognostic indicator for patients with colorectal
cancer. Clin Cancer Res. 10:8465–8471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buchanan FG and DuBois RN: Connecting
COX-2 and Wnt in cancer. Cancer Cell. 9:6–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Humphreys BD, Valerius MT, Kobayashi A,
Mugford JW, Soeung S, Duffield JS, McMahon AP and Bonventre JV:
Intrinsic epithelial cells repair the kidney after injury. Cell
Stem Cell. 2:284–291. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals. 8th.
National Academies Press (US); Washington DC: 2011, PubMed/NCBI
|
|
13
|
Shea K and Geijsen N: Dissection of 6.5
dpc mouse embryos. J Vis Exp. 2:e16010.3791/160. 2007.
|
|
14
|
Hogan B, Costantini F and Lacy E:
Manipulating the Mouse Embryo: A Laboratory Manual. 1st. Cold
Spring Harbor Laboratory Press; NY: pp. 55–60. 1986
|
|
15
|
Zhong X, Wang H and Jian X: Expression of
matrix metalloproteinases-8 and −9 and their tissue inhibitor in
the condyles of diabetic rats with mandibular advancement. Exp Ther
Med. 8:1357–1364. 2014.PubMed/NCBI
|
|
16
|
Ogino S, Meyerhardt JA, Cantor M,
Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K,
Michelini AL, Enzinger PC, et al: Molecular alterations in tumors
and response to combination chemotherapy with gefitinib for
advanced colorectal cancer. Clin Cancer Res. 11:6650–6656. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Heer P, Gosens MJ, de Bruin EC,
Dekker-Ensink NG, Putter H, Marijnen CA, van den Brule AJ, van
Krieken JH, Rutten HJ, Kuppen PJ and van de Velde CJ: Dutch
Colorectal Cancer Group: Cyclooxygenase 2 expression in rectal
cancer is of prognostic significance in patients receiving
preoperative radiotherapy. Clin Cancer Res. 13:2955–2960. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zlobec I, Terracciano LM and Lugli A:
Local recurrence in mismatch repair-proficient colon cancer
predicted by an infiltrative tumor border and lack of CD8+
tumor-infiltrating lymphocytes. Clin Cancer Res. 14:3792–3797.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Henry LR, Lee HO, Lee JS, Klein-Szanto A,
Watts P, Ross EA, Chen WT and Cheng JD: Clinical implications of
fibroblast activation protein in patients with colon cancer. Clin
Cancer Res. 13:1736–1741. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ginty F, Adak S, Can A, Gerdes M, Larsen
M, Cline H, Filkins R, Pang Z, Li Q and Montalto MC: The relative
distribution of membranous and cytoplasmic met is a prognostic
indicator in stage I and II colon cancer. Clin Cancer Res.
14:3814–3822. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Benson AB III: New approaches to assessing
and treating early-stage colon and rectal cancers: Cooperative
group strategies for assessing optimal approaches in early-stage
disease. Clin Cancer Res. 13:6913s–6920s. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morris M, Platell C and Iacopetta B:
Tumor-infiltrating lymphocytes and perforation in colon cancer
predict positive response to 5-fluorouracil chemotherapy. Clin
Cancer Res. 14:1413–1417. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu Y, Richardson JA, Parada LF and Graff
JM: Smad3 mutant mice develop metastatic colorectal cancer. Cell.
94:703–714. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He ZY, Shi CB, Wen H, Li FL, Wang BL and
Wang J: Upregulation of p53 expression in patients with colorectal
cancer by administration of curcumin. Cancer Invest. 29:208–213.
2011. View Article : Google Scholar : PubMed/NCBI
|
